Cargando…
Engineered Human Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus Infection
The 2014–2016 West Africa Ebola virus (EBOV) outbreak coupled with the most recent outbreaks in Central Africa underscore the need to develop effective treatment strategies against EBOV. Although several therapeutic options have shown great potential, developing a wider breadth of countermeasures wo...
Autores principales: | Yu, Yangsheng, Cooper, Christopher L., Wang, Guangshun, Morwitzer, M. Jane, Kota, Krishna, Tran, Julie P., Bradfute, Steven B., Liu, Yan, Shao, Jiayu, Zhang, Amanda K., Luo, Lindsey G., Reid, St. Patrick, Hinrichs, Steven H., Su, Kaihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104201/ https://www.ncbi.nlm.nih.gov/pubmed/32252021 http://dx.doi.org/10.1016/j.isci.2020.100999 |
Ejemplares similares
-
Improved Database Filtering Technology Enables More Efficient Ab Initio Design of Potent Peptides against Ebola Viruses
por: Ripperda, Thomas, et al.
Publicado: (2022) -
Identification of RUVBL1 and RUVBL2 as Novel Cellular Interactors of the Ebola Virus Nucleoprotein
por: Morwitzer, M. Jane, et al.
Publicado: (2019) -
Cathelicidins: Immunomodulatory Antimicrobials
por: van Harten, Roel M., et al.
Publicado: (2018) -
Transformation of Human Cathelicidin LL-37 into Selective,
Stable, and Potent Antimicrobial Compounds
por: Wang, Guangshun, et al.
Publicado: (2014) -
Cathelicidin-Derived Antimicrobial Peptides Inhibit Zika Virus Through Direct Inactivation and Interferon Pathway
por: He, Miao, et al.
Publicado: (2018)